Instituto Nacional de Enfermedades Neoplasicas

Surquillo, Lima region 34

0 studies enrolling now · 2 studies all time

What they study most

Follicular Lymphoma, Melanoma

Studies at this site

• Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma — Running, not enrolling
• A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) — Completed